Kurdish leader Ocalan told the PKK to disband, it did: Here's what to know
The announcement came after the PKK held its congress in northern Iraq on Friday, about two months after its imprisoned founder, Abdullah Ocalan, also known as 'Appo', called on the group to disarm in February.
For most of its history, the PKK has been labelled a terrorist group by Turkiye, the European Union and the United States. It fought for Kurdish autonomy for years, a fight that has been declared over now.
This is all you need to know about why Ocalan and the PKK have given up their armed struggle.
Ocalan was born to a poor Kurdish farming family on April 4, 1948, in Omerli, Sanliurfa, a Kurdish-majority part of Turkiye.
He moved to Ankara to study political science at the university there, where he became politically active; driven, biographers say, by the sense of marginalisation that many Kurds in Turkiye felt.
By the mid-1970s, he was advocating for Kurdish nationalism and went on to found the PKK in 1978.
Six years later, the group launched a separatist rebellion against Turkiye under his command.Ocalan had absolute rule over the PKK and worked to stamp out rival Kurdish groups, monopolising the struggle for Kurdish liberation, according to Blood and Belief: The PKK and the Kurdish Fight for Independence, by Aliza Marcus.
At the time, Kurds were denied the right to speak their language, give their children Kurdish names or show any expression of nationalism.
Despite Ocalan's authoritarian rule, his charisma and positioning as a champion of Kurdish rights led most Kurds across Turkiye to love and respect him, calling him 'Appo', which means Uncle.
Violent.
More than 40,000 people died between 1984 and 2024, with thousands of Kurds fleeing the violence in southeastern Turkiye into cities further north.
Throughout the 1980s and 90s, Ocalan led operations from neighbouring Syria, which was a source of tensions between the then-Assad regime and Turkiye.
The PKK resorted to brutal tactics beginning in the late 1980s and early 90s. According to a report by the European Council on Foreign Relations from 2007, the group, under Ocalan, kidnapped foreign tourists, adopted suicide bombing operations and attacked Turkish diplomatic offices in Europe.
Perhaps even worse, the PKK would repress Kurdish civilians who did not assist the group in its guerrilla warfare.
Eventually, more than a decade after he was caught.
In 1998, Ocalan was forced to flee Syria due to the threat of a Turkish incursion to capture him. A year later, Turkish agents arrested him on a plane in Nairobi, Kenya, thanks to intel received from the US.
He was brought back to Turkiye and handed the death penalty, yet his sentence was changed to life in prison after Turkiye abolished capital punishment in 2004 in a bid to become a member of the EU.
By 2013, Ocalan changed his stance on separatism and began lobbying for comprehensive Kurdish rights and greater regional autonomy in Turkiye, saying he no longer believed in the effectiveness of armed rebellion.
This radical shift led to the start of a shaky peace process between the PKK and the ruling Justice and Development Party (AK Party), headed by Turkish President Recep Tayyip Erdogan.
The peace process led to some freedoms for Kurds, yet fighting erupted between the government and the PKK in 2015 due in part to fears that the party was trying to create a Kurdish statelet in neighbouring Syria during its civil war.
At the time, many Kurds from southern Turkiye had left for Syria to help the Kurds there fight against ISIL (ISIS).
In 2015, the AK Party had also formed a new alliance with the far-right Nationalist Movement Party (MHP), which was staunchly opposed to any peace process involving the PKK.In announcing its disarmament, the PKK said it has 'completed its historical mission' by 'breaking the policy of denial and annihilation of our people and bringing the Kurdish issue to a point where solving it can occur through democratic politics'.
However, analysts argue that there are other reasons behind the decision.
The PKK and its Kurdish allies in the region are more vulnerable than before due to recent developments, according to Sinan Ulgen, an expert on Turkiye and senior fellow at Carnegie Europe in Brussels.
'The reason the PKK gave up its armed struggle has to do with the change in the international context,' Ulgen explained.
US President Donald Trump does not see Syria as a 'strategic focal point' for foreign policy and is, therefore, unlikely to keep supporting Kurdish armed groups in the country as it had during the fight against ISIL, he explained.
In addition, the new government in Syria is on good terms with Turkiye, unlike under the now-overthrown Assad regime.
This new relationship could significantly hurt the ability of the PKK and its Syrian offshoot, the Democratic Union Party (PYD), to operate along the Syria-Turkiye border.
The political climate seems ripe for that.
Main political parties, such as the AK Party and its rival Republican People's Party (CHP), have vocally or tacitly supported a new peace process.
But it was the MHP, long opposed to any overtures to the Kurds, that created the window for a new peace process.
In April 2024, MHP leader Devlet Bahceli invited Ocalan to renounce 'terrorism' in front of Turkiye's parliament in exchange for possible parole.
'The fact it was Bahceli … was kind of unbelievable,' said Sinem Adar, an expert on Turkiye with the German Institute for International and Security Affairs (SWB).
Bahceli's change of heart is probably to help his coalition partner, Erdogan, run in and win the next national election, experts told Al Jazeera.
Under the constitution, Erdogan cannot run for another term unless an early election is called, which needs 360 out of 600 votes in parliament.
To add the votes of Kurdish delegates from the Peoples' Equality and Democracy Party (DEM) to the MHP-AK Party alliance's votes, '[Erdogan] needs to broaden his political support base in parliament over and above the current ruling alliance', Carnegie's Ulgen told Al Jazeera.
It is unclear if he will be released, but his prison conditions could significantly improve, said Ulgen.
He said the government would prefer to gradually increase Ocalan's freedoms, so it can gauge the reactions of his support base and the broader public.
Many people in Turkiye still view Ocalan as a 'terrorist' and blame him for a conflict that has taken the lives of so many.
'I think the government wants to test the waters before allowing Ocalan to go free,' Ulgen told Al Jazeera.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
US-EU trade deal impacts on pharma industry more 'manageable' than expected
A 15% import tariff on pharmaceutical goods from the European Union to the US is going to have a lesser impact on the pharmaceutical industry than Wall Street feared. Big pharmaceutical stocks like Pfizer (PFE), Eli Lilly (LLY), and Johnson & Johnson (JNJ) rose slightly, by about 1%, in trading Thursday after the trade deal was announced, putting to rest concerns of tariffs threatened as high as 200% previously by President Trump. "The two regions have established a 15% tariff cap on imported drugs from EU to the US. This is being viewed by most as both manageable and below the 20%+ rate many expected," wrote Mizuho's healthcare expert Jared Holz in a note to clients Thursday. The deal outlined by the US and EU has multiple parts that impact the pharmaceutical industry, with some clarity still needed. The first is levying either the 15% tariff or the Most Favored Nation (MFN) pricing, whichever is higher, on pharma drugs manufactured in the EU. This puts more emphasis on President Trump's efforts to equalize US drug costs to the lower prices seen in the EU and other developed nations and also impacts a smaller portion of products, as pharma executives have emphasized that most of the branded drugs sold in the US are made in the US. But questions remain on whether the finalize products, or some components, will be taxed. "The United States commits to apply the higher of either the US MFN tariff rate or a tariff rate of 15 percent, comprised of the MFN tariff and a reciprocal tariff, on originating goods of the European Union," according to the White House statement. The second part of the deal is that, as of Sept. 1, the US will enforce MFN pricing on generics and "chemical precursors." The latter refers to active pharmaceutical ingredients, which are the key chemical compounds in any drug. They are cheaper to mass-produce overseas, largely in Asia or Ireland. Experts say that prices for generics, which account for a majority of prescriptions filled in the US, are already low. "The administration is, for the time being, focusing Most Favored Nations pricing on generic products — hoping to peg US prices to that of other countries. Given the already lower cost of generic medicines and net price paid domestically, see the financial ramifications here as more limited than not. Have to look deeper at what precise drugs will be subject to this regulation but for now, not a strategy we see as stifling the industry/major players," Mizuho's Holz said. Its why big generics players, like Teva (TEVA), saw their stocks also rise on the news — up more than 4% Thursday. UBS analyst Ashwani Verma called the trade deal a positive for drugmakers, in a note to clients Thursday. The deal also left wiggle room for additional items: "The United States and the European Union agree to consider other sectors and products that are important for their economies and value chains for inclusion in the list of products for which only the MFN tariffs would apply," according to the White House statement. J.P. Morgan analyst Chris Schott told clients Thursday that clarity on details — including which components are chosen and how the tariffs are levied — as well as the pending results of an investigation by the US Department of Commerce Bureau of Industry and Security, will determine the final impact. In addition, Schott noted that many companies have already stocked up on products in advance of the expected tariff deal, and have inventory through mid-2026. "In the near-term, we see inventory stocking as largely limiting the impact of tariffs through mid-to-late 2026 or longer in some cases," Schott said. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Click here for in-depth analysis of the latest health industry news and events impacting stock prices
3 hours ago
US and EU release details for tariffs on cars, pharmaceuticals
The United States and European Union on Thursday released new details of their trade agreement, including tariff levels for consumer staples like pharmaceuticals and autos. Prior to the agreement last month, the European Union faced the prospect of a 30% tariff rate. Instead, products from one of the largest U.S. trade partners will be slapped with a 15% tariff. In exchange, the EU will remove tariffs on U.S. goods and European companies will aim to buy hundreds of billions of dollars in U.S. products. "This Framework Agreement will put our trade and investment relationship – one of the largest in the world – on a solid footing and will reinvigorate our economies' reindustrialization," the U.S. and EU said in a joint statement on Thursday. The fresh information about product-specific levies and additional European commitments holds implications for consumers and businesses across a wide swathe of the U.S. economy. The European Union purchased about $370 billion worth of U.S. products in 2024, while the U.S. bought about $605 billion worth of European goods, according to the Office of the U.S. Trade Representative, a government agency. The U.S. conducts a greater amount of annual trade with the EU than any individual country. Here's what to know about the U.S.-EU framework agreement released on Thursday: First off, the accord officially establishes a 15% tariff rate for pharmaceuticals from the EU, a top source of U.S. drug imports. Generic pharmaceuticals will be exempt from the new agreement, meaning such drugs will face a roughly 2.5% tariff rate in place prior to the Trump administration. The move ruled out the possibility of a higher tariff rate for pharmaceuticals, for which Trump had previously threatened levies as high as 250%. The new tariffs will take effect on Sept. 1, the joint framework said. Still, price hikes will likely hit pharmaceuticals, Jason Miller, a professor of supply chain management at Michigan State University, previously told ABC News. Pharmaceuticals account for roughly a quarter of U.S. imports from the EU as measured by total value, Miller said. Semiconductors will also face a 15% U.S. tariff under the terms of the agreement, putting the levy well below a 300% rate previously threatened by Trump. Alcohol products, which went unmentioned in the new framework, also appear set for a 15% tariff rate. The new agreement also includes a mechanism that would reduce the auto tariffs faced by European carmakers. Under the plan, the U.S. will reduce the tariffs on vehicles and auto parts from 27.5% to 15%, as long as the EU puts forward legislation that will slash its industrial tariffs. The provision made up a key priority for Brussels. More than one in five European car exports is bound for the U.S., the European Automobile Manufacturers' Association said in March. The lowered auto tariff could help ease upward pressure on car prices in the U.S. In exchange for the tariff relief, the EU said it would remove tariffs on U.S. imports and urge companies to buy hundreds of billions of dollars in U.S. goods. The EU will eliminate tariffs on all U.S. industrial products and provide preferential market access to U.S. producers of seafood and agricultural goods, the joint U.S.-EU statement said. European companies "intend to procure" $750 billion worth of U.S.-made energy-related goods over three years. Also, the EU "intends to purchase at least" $40 billion worth of U.S.-made artificial intelligence chips for its computing centers, the statement said. European firms intend to invest an extra $600 billion "across strategic sectors" in the U.S over the three years, the statement said. The new framework may not be the final say on trade between the two sides. According to the joint statement, the accord amounts to a "first step in a process that can be expanded over time."
Los Angeles Times
3 hours ago
- Los Angeles Times
The U.S. and EU release a bare-bones account of their trade deal, but it's a work in progress
American and European Union officials released a bare-bones account Thursday of their trade deal that imposes a 15% import tax on 70% of European goods exported to the United States, but they left blank key areas such as wine and spirits, as well as steel and indicated that talks would continue on those and a slew of other important sectors. The two sides said the document was only 'a first step in a process that can be further expanded to cover additional areas.' They are dealing with the vast range of goods traded between the two economies in what is the largest bilateral trading relationship in the world, involving $2 trillion in annual trans-Atlantic business. The 3 1/2-page text represents a political commitment and is not legally binding. It contrasts with the typical format for trade agreements, which can be hundreds of pages long and carry legal force. The key provisions are the 15% tariff on most EU goods, a zero rate on U.S. cars and other industrial goods exported to the 27-member EU, and a range of exceptions to the 15% rate for aircraft and aircraft parts, generic pharmaceuticals and pharmaceutical ingredients, with other sectors to be added for goods crucial to each other's economies. Those goods would face lower tariffs from before President Donald Trump's tariff onslaught. 'The EU has agreed to open its $20 Trillion market,' Trump's commerce secretary, Howard Lutnick, said on X. 'The second largest in the world behind the great USA.' He said the deal was 'a major win for American workers, US industries, and our national security. Tariffs should be one of America's favorite words.' European officials have had to defend the deal against dismay from businesses and member governments at the higher tariffs and criticism that the EU gave away too much. European Commission President Ursula von der Leyen sold the deal as granting quick relief from the even higher U.S. tariff on EU cars of 27.5% and as opening the way for further negotiations that could exclude more goods from the 15% tariffs. The deal provides that the lower tariff on cars would apply retroactively from Aug. 1 if the EU can introduce legislation to implement its part of the deal by then, which EU officials say they will do. 'Faced with a challenging situation, we have delivered for our member states and industry and restored clarity and coherence to transatlantic trade,' von der Leyen said. 'This is not the end of the process.' The chief EU trade negotiator, Maros Sefcovic, echoed those sentiments. 'The alternative was a trade war with sky high tariffs ... it builds confidence. It brings stability,' he said. Economists say higher tariffs slow economic growth and will be reflected in higher consumer prices. One category of goods not excluded from tariffs on EU goods was wine and spirits, which had enjoyed zero tariffs on both ends since a 1997 trade deal. Sefcovic, said EU officials had not won an exemption 'yet' but hoped to in future talks and that 'doors are not closed forever' on that issue. That means American distillers face zero tariffs in Europe the short term, but also the possibility of EU retaliation down the line, said Chris Swonger, president and CEO of the Distilled Spirits Council of the United States. 'Without a permanent return to zero-for-zero tariffs on spirits, American distillers do not have the certainty to plan for future export and job growth without the fear of retaliatory tariffs returning,' Swonger said in a statement. The EU has suspended retaliatory tariffs on US goods, including wine and spirits, until Feb. 5, 2026. Proposals to exempt a certain amount of EU steel imports, known as a tariff rate quota, have been left unresolved pending more talks. The 15% tariff is much higher than tariff levels on both sides from before Trump began imposing his tariffs, when they averaged in the low single digits. The tariffs are paid on the U.S. end, either absorbed by American businesses importing the goods, lowering their profits, or passed on to U.S. consumers in the form of higher prices at the cash register. The deal also includes nonbinding EU commitments to purchase $750 billion in U.S. energy and for EU companies to invest $600 billion in the U.S. In both cases, the money would come from private companies and is based on an assessment by the European Commission on what companies were planning to spend. McNeil, McHugh and Hussein write for the Associated Press.
